BS
ZBH icon

Boenning & Scattergood’s Zimmer Biomet ZBH Stock Holding History

Boenning & Scattergood’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$396K Sell
3,100
-20
-0.6% -$2.32K 0.06% 283
2022
Q3 		$326K Buy
3,120
+27
+0.9% +$2.96K 0.07% 282
2022
Q2 		$325K Sell
3,093
-7
-0.2% -$830 0.06% 282
2022
Q1 		$396K Sell
3,100
-65
-2% -$7.83K 0.06% 283
2021
Q4 		$390K Hold
3,165
– – 0.06% 286
2021
Q3 		$449K Sell
3,165
-21
-0.7% -$3.09K 0.08% 255
2021
Q2 		$497K Sell
3,186
-257
-7% -$41.6K 0.09% 244
2021
Q1 		$535K Hold
3,443
– – 0.1% 223
2020
Q4 		$515K Hold
3,443
– – 0.11% 203
2020
Q3 		$455K Buy
3,443
+257
+8% +$33.6K 0.11% 199
2020
Q2 		$369K Hold
3,186
– – 0.1% 214
2020
Q1 		$313K Sell
3,186
-273
-8% -$35.8K 0.11% 194
2019
Q4 		$503K Hold
3,459
– – 0.13% 180
2019
Q3 		$461K Buy
+3,459
New +$447K 0.13% 175

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Boenning & Scattergood's ZBH Position: Q4 2022 in Review

Boenning & Scattergood reduced its Zimmer Biomet (ZBH) stake by 0.64% in Q4 2022, selling an estimated $2.32K and leaving 3,100 shares worth $396K. The position accounts for 0.06% of the portfolio, ranked #283.

Boenning & Scattergood first reported a position in ZBH in Q3 2019 and has held it in 14 quarters since. The position peaked at $535K in Q1 2021. 977 funds tracked by Wall St. Rank hold ZBH as of Q4 2022.

  • Boenning & Scattergood held 3,100 shares of Zimmer Biomet worth $396K as of Q4 2022.
  • Boenning & Scattergood sold 20 Zimmer Biomet shares in Q4 2022, an estimated $2.32K.
  • Zimmer Biomet made up 0.06% of Boenning & Scattergood's portfolio in Q4 2022, its #283 holding.
  • Boenning & Scattergood first reported a position in Zimmer Biomet in Q3 2019 and has held it in 14 quarters since.
  • Boenning & Scattergood's Zimmer Biomet position peaked at $535K in Q1 2021.
  • 977 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2022.

Based on Boenning & Scattergood's 13F filing for Q4 2022, filed 26 Jan 2023.